Cardiovascular Disease in Patients With Diabetes: The Silesia Diabetes-Heart Project
NCT ID: NCT05626413
Last Updated: 2024-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
4000 participants
OBSERVATIONAL
2015-01-01
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Polish Registry of Diabetes (PolReD)
NCT04657367
An International Survey of the Occurrence of Diseases That Affects the Heart and Blood Vessels Among People With Type 2 Diabetes
NCT03786406
Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus
NCT03132129
DETECT-Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment
NCT01076608
Left Ventricular DYsfunction in DiAbetes
NCT01971125
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Machine learning approach will be implemented to discover the association between easy to obtain in everyday practice parameters, namely clinical, biochemical, and demographical ones to identify patients at the highest risk of cardiovascular disease.
The secondary aim of the study is to utilize fundus imaging, electrocardiography, alongside demographic and clinical data in order to potentially diagnose neuropathy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* For the subgroup of patients treated in outpatient diabetology clinics in Silesia region: diabetes type 1 or type 2
Exclusion Criteria
* Types of diabetes other than type 1 and type 2 diabetes
* Death during hospital stay
* Terminal stage of cancer.
2. For the subgroup of patients recruited form outpatient diabetology clinics:
* Lack of an informed consent
* Types of diabetes other than type 1 and type 2 diabetes
* Malignant neoplasms
* Terminal stage of neoplasm
* End-stage renal disease
* Malabsorption syndrome
* Active infection
* Primary hyperparathyroidism
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Silesian University of Technology
OTHER
Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital
UNKNOWN
Medical University of Silesia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katarzyna Nabrdalik, PhD,prof.
Role: PRINCIPAL_INVESTIGATOR
Medical University of Silesia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Internal Diseases, Diabetology and Nephrology
Zabrze, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Janota O, Mantovani M, Kwiendacz H, Irlik K, Bucci T, Lam SHM, Huang B, Alam U, Boriani G, Hendel M, Piasnik J, Olejarz A, Wlosowicz A, Pabis P, Wojcik W, Gumprecht J, Lip GYH, Nabrdalik K. Metabolically "extremely unhealthy" obese and non-obese people with diabetes and the risk of cardiovascular adverse events: the Silesia Diabetes - Heart Project. Cardiovasc Diabetol. 2024 Sep 3;23(1):326. doi: 10.1186/s12933-024-02420-x.
Nabrdalik K, Irlik K, Meng Y, Kwiendacz H, Piasnik J, Hendel M, Ignacy P, Kulpa J, Kegler K, Herba M, Boczek S, Hashim EB, Gao Z, Gumprecht J, Zheng Y, Lip GYH, Alam U. Artificial intelligence-based classification of cardiac autonomic neuropathy from retinal fundus images in patients with diabetes: The Silesia Diabetes Heart Study. Cardiovasc Diabetol. 2024 Aug 10;23(1):296. doi: 10.1186/s12933-024-02367-z.
Nabrdalik K, Kwiendacz H, Irlik K, Hendel M, Drozdz K, Wijata AM, Nalepa J, Janota O, Wojcik W, Gumprecht J, Lip GYH. Machine learning identification of risk factors for heart failure in patients with diabetes mellitus with metabolic dysfunction associated steatotic liver disease (MASLD): the Silesia Diabetes-Heart Project. Cardiovasc Diabetol. 2023 Nov 20;22(1):318. doi: 10.1186/s12933-023-02014-z.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Silesia Diabetes-Heart Project
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.